47 active shortage notices across 11 countries · 1 anticipated.
Last updated 17 Sept 2026 · sourced from official medicines regulators
| Country | Severity | Notices | Since | Est. resolution | Source |
|---|---|---|---|---|---|
| Australia | high | 3 | 31 Jan 2026 | — | TGA |
| New Zealand |
| high |
| 3 |
| 15 Aug 2025 |
| — |
| Pharmac |
| United States | high | 3 | 30 Jun 2025 | — | FDA, FDA MedWatch |
| Colombia | high | 1 | 28 Jun 2024 | — | INVIMA |
| Canada | medium | 12 | 14 Dec 2018 | 13 Nov 2026 | HC |
| Peru | medium | 8 | 13 Jul 2020 | 17 Feb 2028 | DIGEMID |
| Netherlands | medium | 6 | 11 Mar 2026 | — | CBG-MEB |
| Belgium | medium | 5 | 11 Feb 2026 | 7 Aug 2026 | FAMHP |
| Spain | medium | 3 | 28 Jan 2021 | 30 Oct 2026 | AEMPS |
| India | medium | 2 | 1 May 2026 | — | CDSCO |
| Croatia | medium | 1 | 10 May 2026 | — | HALMED |
Clinically related options from Mederti's curated alternatives data. Always confirm suitability with a pharmacist or prescriber before substituting.
Yes. As of the latest regulator updates, Omeprazole has 47 active shortage notices across 11 countries (Australia, New Zealand, United States, Colombia, Canada, Peru and more). Status is refreshed daily from official regulatory sources.
Regulators attribute the current Omeprazole shortages to manufacturing problems, supply-chain disruption, product discontinuation. The exact cause varies by country and product — each notice on this page links to the official source.
Regulator-estimated resolution dates currently range from 11 Nov 2022 to 17 Feb 2028, depending on country and product. These estimates come from the manufacturers via regulators and often change — check the per-country table above for the latest.
Mederti lists 2 clinically related alternatives for Omeprazole (see the alternatives section above). Alternatives require clinical judgement — always confirm suitability with a pharmacist or prescriber and your national guidance before substituting.
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ regulators across 50+ countries and never publishes unsourced shortage claims.
Famotidine · Cimetidine(200 Mg) · Esomeprazol · Cytotec 200 Microgram Tablets (Misoprostol) · Ranitidine · Aurobindo Ranitidine Capsules
Free for individual pharmacists and clinicians — watchlists, email alerts, alternatives and country-by-country product detail.
Create a free accountData on this page is aggregated from official national medicines regulators and updated daily. It is provided for information only and requires verification before clinical use. Mederti is not affiliated with or endorsed by any regulator.